As filed with the Securities and Exchange
Commission on September 8, 2006.                     Registration No. 333-136585

================================================================================



                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                AMENDMENT NO. 1
                                       TO

                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                              TARRANT APPAREL GROUP
             (Exact Name of Registrant as Specified in Its Charter)

           CALIFORNIA                                            95-4181026
  (State or Other Jurisdiction                                (I.R.S. Employer
of Incorporation or Organization)                            Identification No.)

                         3151 EAST WASHINGTON BOULEVARD
                          LOS ANGELES, CALIFORNIA 90023
                                 (323) 780-8250
    (Address, Including Zip Code, and Telephone Number, Including Area Code,
                  of Registrant's Principal Executive Offices)

                      GERARD GUEZ, CHIEF EXECUTIVE OFFICER
                         3151 EAST WASHINGTON BOULEVARD
                          LOS ANGELES, CALIFORNIA 90023
                                 (323) 780-8250
       (Name, Address, Including Zip Code, and Telephone Number, Including
                        Area Code, of Agent for Service)

                                   COPIES TO:
                             John J. McIlvery, Esq.
                         Stubbs Alderton & Markiles, LLP
                        15260 Ventura Boulevard, Floor 20
                         Sherman Oaks, California 91403
                                 (818) 444-4500

         APPROXIMATE  DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:  From
time to time after the effective date of this Registration Statement.

         If the only  securities  on this form are  being  offered  pursuant  to
dividend or interest reinvestment plans, please check the following box. [_]

         If any of the  securities  being  registered  on  this  form  are to be
offered  on a  delayed  or  continuous  basis  pursuant  to Rule 415  under  the
Securities Act of 1933,  other than  securities  offered only in connection with
dividend or interest reinvestment plans, check the following box. [x]

         If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list  the  Securities  Act  registration  statement  number  of the  earlier
effective registration statement for the same offering. [_]

         If this  Form is a  post-effective  amendment  filed  pursuant  to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act  registration   statement  number  of  the  earlier  effective  registration
statement for the same offering. [_]

         If  this  Form  is  a  registration   statement   pursuant  to  General
Instructions  I.D.  or a  post-effective  amendment  thereto  that shall  become
effective  upon filing  with the  Commission  pursuant to Rule 462(e)  under the
Securities Act, check the following box. [_]

         If this Form is a post-effective  amendment to a registration statement
filed  pursuant  to  General  Instruction  I.D.  filed  to  register  additional
securities or additional classes of securities pursuant to Rule 413(b) under the
Securities Act, check the following box. [_]



         THE REGISTRANT HEREBY AMENDS THIS  REGISTRATION  STATEMENT ON SUCH DATE
OR DATES AS MAY BE NECESSARY TO DELAY ITS  EFFECTIVE  TIME UNTIL THE  REGISTRANT
SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY  STATES THAT THIS REGISTRATION
STATEMENT SHALL  THEREAFTER  BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE  SECURITIES  ACT OF 1933 OR UNTIL THE  REGISTRATION  STATEMENT  SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION,  ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.






                     SUBJECT TO COMPLETION - September 8, 2006


                                   PROSPECTUS

                              TARRANT APPAREL GROUP

                        4,917,859 SHARES OF COMMON STOCK
                                 (no par value)

                                   ----------

         This  prospectus  relates to the offer and sale from time to time of up
to 4,917,859 shares of our common stock that are held by the shareholders  named
in the  "Selling  Shareholders"  section of this  prospectus.  The shares of our
common stock offered  pursuant to this prospectus were originally  issued to the
selling  shareholders  pursuant to their exercise of warrants to purchase common
stock.

         The  prices at which the  selling  shareholders  may sell the shares in
this offering will be determined by the  prevailing  market price for the shares
or in negotiated transactions.  We will not receive any of the proceeds from the
sale of the  shares.  We will bear all  expenses  of  registration  incurred  in
connection with this offering.  The selling  shareholders whose shares are being
registered  will  bear  all  broker  and  similar  commissions  of  the  selling
shareholders.


         Our common stock is traded on the NASDAQ  National  Market System under
the symbol  "TAGS."  On September 7, 2006, the last  reported  sale price of the
common stock on the NASDAQ National Market System was $1.70 per share.


         SEE  "RISK  FACTORS"  BEGINNING  ON PAGE 4 TO READ  ABOUT THE RISKS YOU
SHOULD CONSIDER CAREFULLY BEFORE BUYING SHARES OF OUR COMMON STOCK.

                                   ----------

         Neither the Securities and Exchange Commission nor any state securities
commission has approved or  disapproved  of these  securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a
criminal offense.

                                   ----------

                  The date of this prospectus is ______________





                                TABLE OF CONTENTS

                                                                            PAGE

PROSPECTUS SUMMARY...........................................................  3

RISK FACTORS.................................................................  4

FORWARD-LOOKING STATEMENTS................................................... 10

USE OF PROCEEDS.............................................................. 10

SELLING SHAREHOLDERS......................................................... 11

PLAN OF DISTRIBUTION......................................................... 15

WHERE YOU CAN FIND MORE INFORMATION.......................................... 17

LEGAL MATTERS................................................................ 18

EXPERTS...................................................................... 18


                                       2



                               PROSPECTUS SUMMARY

ABOUT TARRANT APPAREL GROUP

         Tarrant  Apparel  Group is a design and  sourcing  company  for private
label and private brand casual apparel  serving mass  merchandisers,  department
stores, branded wholesalers and specialty chains located primarily in the United
States. Our major customers include leading retailers,  such as Kohl's, Chico's,
Macy's Merchandising Group, Mervyn's, Mothers Work, Sears, Wal-Mart,  Dillard's,
the Avenue,  Lane Bryant,  Lerner New York,  and J.C.  Penney.  Our products are
manufactured in a variety of woven and knit fabrications and include jeans wear,
casual pants,  t-shirts,  shorts,  blouses,  shirts and other tops,  dresses and
jackets. Our private brands include American Rag Cie and Alain Weiz.

ABOUT THE OFFERING

         This  prospectus may be used only in connection  with the resale by the
selling shareholders of up to 4,917,859 shares of our common stock issuable upon
exercise of warrants.


         We will not receive any proceeds  from the sale of the shares of common
stock offered by the selling shareholders using this prospectus. On September 6,
2006 we had 30,543,763 shares of common stock outstanding.


CORPORATE INFORMATION

         We were  incorporated  in California in September  1988.  Our executive
offices are located at 3151 East Washington Boulevard,  Los Angeles,  California
90023, and our telephone  number is (323) 780-8250.  Information on our website,
www.tags.com, does not constitute part of this prospectus.


                                       3



                                  RISK FACTORS

         YOU SHOULD CAREFULLY  CONSIDER THE FOLLOWING RISKS BEFORE YOU DECIDE TO
BUY OUR  COMMON  STOCK.  THE RISKS  AND  UNCERTAINTIES  DESCRIBED  BELOW ARE THE
MATERIAL ONES FACING OUR COMPANY.  IF ANY OF THE FOLLOWING RISKS ACTUALLY OCCUR,
OUR BUSINESS,  FINANCIAL CONDITION OR RESULTS OF OPERATIONS WOULD LIKELY SUFFER.
IF THIS OCCURS, THE TRADING PRICE OF OUR COMMON STOCK COULD DECLINE, AND YOU MAY
LOSE ALL OR PART OF THE MONEY YOU PAID TO BUY OUR COMMON STOCK.

RISKS RELATED TO THIS OFFERING

THE ULTIMATE RESOLUTION OF THE INTERNAL REVENUE SERVICE'S EXAMINATION OF OUR TAX
RETURNS MAY REQUIRE US TO INCUR AN EXPENSE  BEYOND WHAT HAS BEEN RESERVED FOR ON
OUR BALANCE SHEET OR MAKE CASH PAYMENTS BEYOND WHAT WE ARE THEN ABLE TO PAY.

         In January 2004, the Internal Revenue Service  proposed  adjustments to
increase  our federal  income tax payable for the years ended  December 31, 1996
through  2001.  This  adjustment  would also result in  additional  state taxes,
penalties  and  interest.  In  addition,  in July  2004,  the IRS  initiated  an
examination  of our Federal  income tax return for the year ended  December  31,
2002. In March 2005,  the IRS proposed an  adjustment  to our taxable  income of
approximately $6 million related to similar issues  identified in their audit of
the 1996  through  2001  federal  income tax  returns.  We believe  that we have
meritorious   defenses  to  and  intend  to  vigorously   contest  the  proposed
adjustments  made to our  federal  income tax  returns  for the years ended 1996
through 2002. If the proposed  adjustments are upheld through the administrative
and legal  process,  they could have a material  impact on our earnings and cash
flow.  We  believe  we  have  provided  adequate  reserves  for  any  reasonably
foreseeable outcome related to these matters on the consolidated  balance sheets
included in the Consolidated Financial Statements. The maximum amount of loss in
excess of the amount accrued in the financial statements is $7.7 million. If the
amount  of any  actual  liability,  however,  exceeds  our  reserves,  we  would
experience an immediate adverse earnings impact in the amount of such additional
liability,  which  could  be  material.  Additionally,  we  anticipate  that the
ultimate  resolution of these matters will require that we make significant cash
payments to the taxing authorities.  Presently we do not have sufficient cash on
hand to make any future payments that may be required. No assurance can be given
that we will have sufficient  surplus cash from operations or borrowing  ability
to make the required  payments.  Additionally,  any cash used for these purposes
will not be available for other corporate purposes,  which could have a material
adverse effect on our financial condition and results of operations.

INSIDERS OWN A SIGNIFICANT  PORTION OF OUR COMMON  STOCK,  WHICH COULD LIMIT OUR
SHAREHOLDERS' ABILITY TO INFLUENCE THE OUTCOME OF KEY TRANSACTIONS.

         As of June 30, 2006,  our  executive  officers and  directors and their
affiliates  owned  approximately  43% of the  outstanding  shares of our  common
stock.  Gerard Guez, our Chairman and Interim Chief Executive Officer,  and Todd
Kay, our Vice Chairman, alone own approximately 33.1% and 8.4%, respectively, of
the outstanding  shares of our common stock at June 30, 2006.  Accordingly,  our
executive  officers and directors  have the ability to affect the outcome of, or
exert considerable  influence over, all matters requiring  shareholder approval,
including the election and removal of directors and any change in control.  This
concentration of ownership of our common stock could have the effect of delaying
or preventing a change of control of us or otherwise  discouraging or preventing
a potential  acquirer from  attempting  to obtain  control of us. This, in turn,
could have a negative  effect on the market price of our common stock.  It could
also prevent our  shareholders  from  realizing a premium over the market prices
for their shares of common stock.


                                       4



WE HAVE ADOPTED A NUMBER OF ANTI-TAKEOVER MEASURES THAT MAY DEPRESS THE PRICE OF
OUR COMMON STOCK.

         Our shareholders rights plan, our ability to issue additional shares of
preferred stock and some provisions of our articles of incorporation  and bylaws
could make it more difficult for a third party to make an  unsolicited  takeover
attempt of us. These anti-takeover  measures may depress the price of our common
stock by making it more difficult for third parties to acquire us by offering to
purchase  shares of our stock at a premium to its market price without  approval
of our board of directors.

OUR STOCK PRICE HAS BEEN VOLATILE.

         Our common stock is quoted on the NASDAQ  National  Market System,  and
there can be substantial volatility in the market price of our common stock. The
market  price of our common  stock has been,  and is likely to  continue  to be,
subject  to  significant  fluctuations  due to a variety of  factors,  including
quarterly variations in operating results, operating results which vary from the
expectations  of  securities  analysts  and  investors,   changes  in  financial
estimates,  changes in market valuations of competitors,  announcements by us or
our competitors of a material nature,  loss of one or more customers,  additions
or  departures of key  personnel,  future sales of common stock and stock market
price and volume  fluctuations.  In  addition,  general  political  and economic
conditions such as a recession,  or interest rate or currency rate  fluctuations
may adversely affect the market price of our common stock.

         In addition,  the stock market in general has experienced extreme price
and volume fluctuations that have affected the market price of our common stock.
Often, price fluctuations are unrelated to operating performance of the specific
companies whose stock is affected.  In the past, following periods of volatility
in the market price of a company's stock, securities class action litigation has
occurred  against  the  issuing  company.  If we were  subject  to this  type of
litigation in the future,  we could incur  substantial  costs and a diversion of
our  management's  attention and resources,  each of which could have a material
adverse effect on our revenue and earnings.  Any adverse  determination  in this
type of litigation could also subject us to significant liabilities.

ABSENCE OF DIVIDENDS COULD REDUCE OUR ATTRACTIVENESS TO YOU.

         Some investors  favor  companies that pay  dividends,  particularly  in
general  downturns  in the stock  market.  We have not declared or paid any cash
dividends on our common stock. We currently intend to retain any future earnings
for funding growth, and we do not currently  anticipate paying cash dividends on
our  common  stock  in the  foreseeable  future.  Additionally,  we  cannot  pay
dividends on our common stock unless the terms of our bank credit facilities and
outstanding  preferred  stock,  if any,  permit the payment of  dividends on our
common stock.  Because we may not pay dividends,  your return on this investment
likely depends on your selling our stock at a profit.

RISKS RELATED TO OUR BUSINESS

WE DEPEND ON A GROUP OF KEY CUSTOMERS FOR A SIGNIFICANT  PORTION OF OUR SALES. A
SIGNIFICANT  ADVERSE  CHANGE  IN A  CUSTOMER  RELATIONSHIP  OR  IN A  CUSTOMER'S
FINANCIAL POSITION COULD HARM OUR BUSINESS AND FINANCIAL CONDITION.

         Four customers  collectively accounted for approximately 55% of our net
sales in first six months of 2006. We believe that  consolidation  in the retail
industry  has  centralized  purchasing  decisions  and given  customers  greater
leverage over suppliers,  like us, and we expect this trend to continue. If this
consolidation  continues,  our  net  sales  and  results  of  operations  may be
increasingly  sensitive to deterioration in the financial condition of, or other
adverse developments with, one or more of our customers.


                                       5



         While we have long-standing customer relationships, we generally do not
have  long-term   contracts  with  them.   Purchases   generally   occur  on  an
order-by-order  basis, and  relationships  exist as long as there is a perceived
benefit to both parties.  A decision by a major customer,  whether  motivated by
competitive considerations,  financial difficulties,  and economic conditions or
otherwise,  to decrease its  purchases  from us or to change its manner of doing
business with us, could adversely  affect our business and financial  condition.
In addition,  during  recent years,  various  retailers,  including  some of our
customers,  have experienced  significant  changes and  difficulties,  including
consolidation of ownership,  increased  centralization of purchasing  decisions,
restructurings, bankruptcies and liquidations.

         These and other financial problems of some of our retailers, as well as
general  weakness  in the retail  environment,  increase  the risk of  extending
credit  to  these  retailers.   A  significant  adverse  change  in  a  customer
relationship  or in a customer's  financial  position could cause us to limit or
discontinue  business with that customer,  require us to assume more credit risk
relating to that  customer's  receivables,  limit our ability to collect amounts
related to previous purchases by that customer, or result in required prepayment
of our  receivables  securitization  arrangements,  all of which  could harm our
business and financial condition.

FAILURE OF THE  TRANSPORTATION  INFRASTRUCTURE TO MOVE SEA FREIGHT IN ACCEPTABLE
TIME FRAMES COULD ADVERSELY AFFECT OUR BUSINESS.

         Because the bulk of our  freight is  designed to move  through the West
Coast ports in  predictable  time frames,  we are at risk of  cancellations  and
penalties when those ports operate inefficiently creating delays in delivery. We
experienced  such  delays  from  June  2004  until  November  2004,  and  we may
experience  similar  delays  in  the  future  especially  during  peak  seasons.
Unpredictable  timing for  shipping  may cause us to utilize  air freight or may
result in customer  penalties for late  delivery,  any of which could reduce our
operating margins and adversely affect our results of operations.

UNPREDICTABLE  DELAYS  AS  THE  RESULT  OF  INCREASED  AND  INTENSIFIED  CUSTOMS
ACTIVITY.

         U.S.  Customs has stepped up efforts to  scrutinize  imports  from Hong
Kong in order to verify all details of  shipments  under the OPA rules  allowing
certain  processes to be performed in China without shipping under China country
of origin  documentation.  Such "detentions" are unpredictable and cause serious
interruption of normally expected freight movement timetables.

THE  OUTCOME OF  LITIGATION  IN WHICH WE ARE  INVOLVED IS  UNPREDICTABLE  AND AN
ADVERSE  DECISION IN ANY SUCH MATTER COULD HAVE A MATERIAL ADVERSE AFFECT ON OUR
FINANCIAL POSITION AND RESULTS OF OPERATIONS.

         We are  currently  in  litigation  with the  licensors  of the  Jessica
Simpson  brands  regarding our rights to sell apparel  under these  brands.  The
licensor has filed a counterclaim  against us seeking damages.  These claims may
divert  financial  and  management  resources  that would  otherwise  be used to
benefit our operations. Although we believe that we have meritorious defenses to
the claims made  against us, and intend to contest  the lawsuit  vigorously,  no
assurances  can be given that the results of these  matters will be favorable to
us. An adverse resolution of any of these lawsuits could have a material adverse
affect on our financial  position and results of  operations.  Additionally,  we
have incurred significant legal fees in this litigation,  and unless the case is
settled,  we will continue to incur additional legal fees in increasing  amounts
as the case accelerates to trial.


                                       6



FAILURE TO MANAGE OUR GROWTH AND EXPANSION COULD IMPAIR OUR BUSINESS.

         Since our inception,  we have experienced  periods of rapid growth.  No
assurance can be given that we will be successful in  maintaining  or increasing
our sales in the  future.  Any future  growth in sales will  require  additional
working capital and may place a significant strain on our management, management
information systems,  inventory  management,  sourcing capability,  distribution
facilities and receivables  management.  Any disruption in our order processing,
sourcing or  distribution  systems  could cause orders to be shipped  late,  and
under  industry  practices,  retailers  generally can cancel orders or refuse to
accept goods due to late shipment.  Such  cancellations and returns would result
in a reduction in revenue,  increased  administrative  and shipping  costs and a
further burden on our distribution facilities.

OUR OPERATING RESULTS MAY FLUCTUATE SIGNIFICANTLY.

         We have experienced, and expect to continue to experience,  substantial
variations  in our net sales and operating  results from quarter to quarter.  We
believe that the factors which influence this  variability of quarterly  results
include  the  timing of our  introduction  of new  product  lines,  the level of
consumer  acceptance  of each new product  line,  general  economic and industry
conditions  that  affect  consumer   spending  and  retailer   purchasing,   the
availability of manufacturing  capacity, the seasonality of the markets in which
we participate,  the timing of trade shows,  the product mix of customer orders,
the timing of the placement or  cancellation  of customer  orders,  the weather,
transportation  delays, the occurrence of charge backs in excess of reserves and
the timing of  expenditures  in  anticipation  of increased sales and actions of
competitors.  Due to  fluctuations  in our revenue and  operating  expenses,  we
believe that period-to-period comparisons of our results of operations are not a
good  indication of our future  performance.  It is possible that in some future
quarter or quarters,  our operating  results will be below the  expectations  of
securities analysts or investors.  In that case, our stock price could fluctuate
significantly or decline.

WE DEPEND ON OUR COMPUTER AND COMMUNICATIONS SYSTEMS.

         As  a  multi-national   corporation,   we  rely  on  our  computer  and
communication  network to operate efficiently.  Any interruption of this service
from power loss,  telecommunications  failure, weather, natural disasters or any
similar  event  could  have  a  material  adverse  affect  on our  business  and
operations. Additionally, hackers and computer viruses have disrupted operations
at many major companies. We may be vulnerable to similar acts of sabotage, which
could have a material adverse effect on our business and operations.

WE MAY REQUIRE ADDITIONAL CAPITAL IN THE FUTURE.

         We may not be able to fund our  future  growth or react to  competitive
pressures if we lack sufficient funds.  Currently, we believe we have sufficient
cash on hand and cash  available  through  our credit  facilities,  issuance  of
long-term  debt and equity  securities,  and proceeds from the exercise of stock
options to fund existing operations for the foreseeable future.  However, in the
future we may need to raise  additional  funds through equity or debt financings
or collaborative relationships. This additional funding may not be available or,
if  available,  it may not be available on  economically  reasonable  terms.  In
addition,  any additional funding may result in significant dilution to existing
shareholders. If adequate funds are not available, we may be required to curtail
our operations or obtain funds through  collaborative  partners that may require
us to release material rights to our products.


                                       7



OUR BUSINESS IS SUBJECT TO RISKS ASSOCIATED WITH IMPORTING PRODUCTS.

         Substantially  all of our  import  operations  are  subject  to tariffs
imposed on imported  products,  safeguards and growth  targets  imposed by trade
agreements. In addition, the countries in which our products are manufactured or
imported may from time to time impose  additional  new duties,  tariffs or other
restrictions on our imports or adversely modify existing  restrictions.  Adverse
changes in these import costs and  restrictions,  or our  suppliers'  failure to
comply with customs or similar laws,  could harm our business.  We cannot assure
that future trade  agreements will not provide our competitors with an advantage
over us, or increase our costs,  either of which could have an adverse effect on
our business and financial condition.

         Our operations are also subject to the effects of  international  trade
agreements and regulations such as the North American Free Trade Agreement,  and
the activities and regulations of the World Trade Organization. Generally, these
trade  agreements  benefit our  business by reducing or  eliminating  the duties
assessed  on products  manufactured  in a  particular  country.  However,  trade
agreements can also impose requirements that adversely affect our business, such
as limiting the  countries  from which we can purchase raw materials and setting
duties or  restrictions  on products that may be imported into the United States
from a  particular  country.  In  addition,  the World  Trade  Organization  may
commence a new round of trade  negotiations  that  liberalize  textile  trade by
further  eliminating  or reducing  tariffs.  The  elimination of quotas on World
Trade Organization  member countries in 2005 has resulted in explosive growth in
textile imports from China, and subsequent  safeguard measures including embargo
of  certain  China  country of origin  products.  Actions  taken to avoid  these
measures caused  disruption,  and a negative impact on margins.  Such disruption
may continue to affect us to some extent in the future.

OUR DEPENDENCE ON INDEPENDENT  MANUFACTURERS  REDUCES OUR ABILITY TO CONTROL THE
MANUFACTURING  PROCESS,  WHICH  COULD HARM OUR  SALES,  REPUTATION  AND  OVERALL
PROFITABILITY.

         We depend on independent contract  manufacturers to secure a sufficient
supply of raw  materials  and  maintain  sufficient  manufacturing  and shipping
capacity in an environment  characterized by declining  prices,  labor shortage,
continuing  cost  pressure  and  increased  demands for product  innovation  and
speed-to-market.  This  dependence  could  subject us to difficulty in obtaining
timely delivery of products of acceptable quality.  In addition,  a contractor's
failure  to ship  products  to us in a timely  manner  or to meet  the  required
quality  standards could cause us to miss the delivery date  requirements of our
customers.  The failure to make timely  deliveries  may cause our  customers  to
cancel  orders,  refuse  to accept  deliveries,  impose  non-compliance  charges
through  invoice  deductions or other  charge-backs,  demand  reduced  prices or
reduce future orders, any of which could harm our sales,  reputation and overall
profitability.  We do not  have  material  long-term  contracts  with any of our
independent  contractors and any of these contractors may unilaterally terminate
their  relationship with us at any time. To the extent we are not able to secure
or maintain relationships with independent  contractors that are able to fulfill
our requirements, our business would be harmed.

         We have  initiated a factory  compliance  agreement with our suppliers,
and monitor our independent  contractors' compliance with applicable labor laws,
but we do not control our contractors or their labor practices. The violation of
federal,  state or foreign labor laws by one of the our contractors could result
in our being subject to fines and our goods that are  manufactured  in violation
of such laws being seized or their sale in interstate commerce being prohibited.
From  time to  time,  we  have  been  notified  by  federal,  state  or  foreign
authorities that certain of our contractors are the subject of investigations or
have been found to have  violated  applicable  labor laws.  To date, we have not
been subject to any sanctions that, individually or in the aggregate, have had a
material  adverse  effect on our business,  and we are not aware of any facts on
which any such  sanctions  could be based.  There can be no assurance,  however,
that in the future we will not be subject to sanctions as a result of violations
of applicable  labor laws by our  contractors,  or that such  sanctions will not
have a material  adverse  effect on our business and results of  operations.  In
addition,  certain of our customers,  require strict compliance by their apparel
manufacturers, including us, with


                                       8



applicable labor laws and visit our facilities often.  There can be no assurance
that the violation of applicable  labor laws by one of our contractors  will not
have a material adverse effect on our relationship with our customers.

OUR DEPENDENCE ON THIRD PARTIES FOR BRANDED APPAREL PRODUCTS REDUCES OUR ABILITY
TO CONTROL THE MARKETING  PROCESS,  WHICH COULD HARM OUR SALES,  REPUTATION  AND
OVERALL PROFITABILITY.

         For certain branded apparel lines, in particular  celebrity  brands, we
depend on the cooperation and efforts of the celebrity personality and/or master
licensor to support our design and  marketing  efforts for apparel  products.  A
celebrity's  failure to adequately support our marketing efforts could adversely
affect the sales for new products and lines. In addition,  we are subject to the
terms of our agreements  with the master licensor for licensed  brands,  and our
rights to exploit certain brands may therefore be limited. Further, we may, from
time to time,  become involved in disputes with the master licensor with respect
to our  contractual  relationship.  To the  extent  we are not  able to  receive
adequate  support from the master  licensor  and/or  celebrity or maintain  good
working relationships with master licensors, our business would be harmed.

OUR  BUSINESS IS SUBJECT TO RISKS OF  OPERATING  IN A FOREIGN  COUNTRY AND TRADE
RESTRICTIONS.

         Approximately  90% of our products  were imported from outside the U.S.
in fiscal 2005. We are subject to the risks  associated  with doing  business in
foreign  countries,  including,  but not limited to,  transportation  delays and
interruptions,  political instability,  expropriation, currency fluctuations and
the imposition of tariffs, import and export controls, other non-tariff barriers
and cultural  issues.  Any changes in those countries' labor laws and government
regulations may have a negative effect on our profitability.

RISK ASSOCIATED WITH OUR INDUSTRY

OUR SALES ARE HEAVILY INFLUENCED BY GENERAL ECONOMIC CYCLES.

         Apparel  is a cyclical  industry  that is  heavily  dependent  upon the
overall level of consumer spending.  Purchases of apparel and related goods tend
to be highly  correlated with cycles in the disposable  income of our consumers.
Our customers  anticipate and respond to adverse changes in economic  conditions
and uncertainty by reducing  inventories and canceling orders. As a result,  any
substantial deterioration in general economic conditions,  increases in interest
rates,  acts of war,  terrorist  or  political  events  that  diminish  consumer
spending and confidence in any of the regions in which we compete,  could reduce
our sales and adversely affect our business and financial condition.

OUR BUSINESS IS HIGHLY COMPETITIVE AND DEPENDS ON CONSUMER SPENDING PATTERNS.

         The  apparel  industry  is highly  competitive.  We face a  variety  of
competitive challenges including:

         o        anticipating  and  quickly  responding  to  changing  consumer
                  demands;

         o        developing innovative,  high-quality products in sizes, colors
                  and styles that appeal to  consumers of varying age groups and
                  tastes;

         o        competitively  pricing our  products  and  achieving  customer
                  perception of value; and

         o        the need to provide strong and effective marketing support.


                                        9



WE MUST SUCCESSFULLY  GAUGE FASHION TRENDS AND CHANGING CONSUMER  PREFERENCES TO
SUCCEED.

         Our success is largely  dependent upon our ability to gauge the fashion
tastes of our customers and to provide  merchandise  that  satisfies  retail and
customer demand in a timely manner. The apparel business fluctuates according to
changes in consumer  preferences  dictated in part by fashion and season. To the
extent we misjudge  the market for our  merchandise;  our sales may be adversely
affected.  Our ability to anticipate and effectively respond to changing fashion
trends depends in part on our ability to attract and retain key personnel in our
design,  merchandising  and marketing staff.  Competition for these personnel is
intense,  and we  cannot be sure that we will be able to  attract  and  retain a
sufficient number of qualified personnel in future periods.

OUR BUSINESS IS SUBJECT TO SEASONAL TRENDS.

         Historically,  our  operating  results  have been  subject to  seasonal
trends when measured on a quarterly  basis.  This trend is dependent on numerous
factors,  including the markets in which we operate,  holiday seasons,  consumer
demand,  climate,  economic  conditions  and numerous  other factors  beyond our
control.  There can be no assurance  that our historic  operating  patterns will
continue in future  periods as we cannot  influence  or  forecast  many of these
factors.

                           FORWARD-LOOKING STATEMENTS

         This prospectus  contains  statements  that constitute  forward-looking
statements  within the meaning of Section 27A of the  Securities Act of 1933 and
Section 21E of the Exchange Act of 1934, both as amended.  These forward-looking
statements are subject to various risks and  uncertainties.  The words "expect,"
"estimate,"  "anticipate," "predict," "believe," "intend," "plan," "continuing,"
"ongoing"  and  similar  expressions  and  variations  thereof  are  intended to
identify  forward-looking  statements.  Such  statements  appear  in a number of
places in this prospectus and include statements regarding our intent, belief or
current  expectations  regarding our strategies,  future sales,  other plans and
objectives,  our ability to design, develop, source and market products, or fund
our  operations  or  acquistions,  and the ability of our products to achieve or
maintain  commercial   acceptance.   Any  forward-looking   statements  are  not
guarantees of future  performance  and involve risks and  uncertainties.  Actual
results may differ  materially from those projected in this prospectus,  for the
reasons,  among others,  described in the Risk Factors section beginning on page
4. You should  read the Risk  Factors  section  carefully,  and should not place
undue  reliance on any  forward-looking  statements,  which speak only as of the
date of this  prospectus.  We undertake no  obligation  to release  publicly any
updated  information  about  forward-looking  statements  to  reflect  events or
circumstances  occurring  after the date of this  prospectus  or to reflect  the
occurrence of unanticipated events.

                                 USE OF PROCEEDS

         The proceeds from the sale of each selling  shareholder's  common stock
will belong to that selling  shareholder.  We will not receive any proceeds from
such sales.

         We may receive additional proceeds upon exercise of the warrants issued
to the selling shareholders. To the extent we receive any proceeds upon exercise
of the  warrants,  we intend to use such  proceeds for general  working  capital
purposes.


                                       10



                              SELLING SHAREHOLDERS

CREDIT FACILITY WITH GUGGENHEIM CORPORATE FUNDING LLC AND ISSUANCE OF WARRANTS

         On June 16,  2006,  we entered  into a Credit  Agreement  with  various
lenders and with Guggenheim  Corporate Funding LLC, as administrative  agent and
collateral  agent for the lenders (the "Agent").  This credit facility  provides
for borrowings of up to $65 million.  This facility  consists of an initial term
loan of up to $25  million,  of which we borrowed  $15.5  million at the initial
funding,  to be used to repay  certain  existing  indebtedness  and fund general
operating  and  working  capital  needs.  An  additional  term loan of up to $40
million will be available under this facility to finance acquisitions acceptable
to the  Agent.  All  amounts  under the term  loans  become  due and  payable in
December  2010.  Interest  under this  facility is payable  quarterly,  with the
interest  rate equal to the LIBOR rate plus an  applicable  margin  based on our
debt leverage ratio (as defined in the credit agreement).  Our obligations under
the Guggenheim  credit facility are secured by a lien on  substantially  all the
assets of Tarrant  Apparel  Group and our  domestic  subsidiaries,  including  a
pledge of the  equity  interests  of our  domestic  subsidiaries  and 65% of our
Luxembourg  subsidiary.   This  credit  facility  contains  customary  financial
covenants,  including  covenants  that we maintain  minimum levels of EBITDA and
interest  coverage  ratios and  limitations  on  additional  indebtedness.  This
facility includes customary default provisions,  and all outstanding obligations
may become immediately due and payable in the event of a default.

         In connection with  Guggenheim  credit  facility,  on June 16, 2006, we
issued Midland National Life Insurance Company,  North American Company for Life
and Health Insurance and Orpheus Holdings, LLC, the lenders under this facility,
warrants to purchase up to an aggregate of 3,857,143 shares of our common stock.
These  warrants have a term of 10 years.  These  warrants are  exercisable  at a
price of $1.88 per share with respect to 20% of the shares, $2.00 per share with
respect to 20% of the shares, $3.00 per share with respect to 20% of the shares,
$3.75 per share  with  respect  to 20% of the  shares  and $4.50 per share  with
respect to 20% of the shares.  The exercise prices are subject to adjustment for
certain dilutive events pursuant to the terms of the warrants.  A portion of the
warrants will not become exercisable unless and until a specified portion of the
initial term loan is actually funded by the lenders.

         Durham Capital  Corporation acted as our advisor in connection with the
Guggenheim credit facility.  As compensation for its services,  we agreed to pay
Durham  Capital a cash fee in an amount equal to 1% of the  committed  principal
amount of the loans under the Guggenheim credit facility. In addition, we issued
Durham  Capital a warrant to purchase  77,143 shares of our common  stock.  This
warrant has a term of 10 years and is  exercisable  at price of $1.88 per share,
subject to adjustment  for certain  dilutive  events.  A portion of this warrant
will not become  exercisable unless and until a specified portion of the initial
term loan is actually funded by the lenders.

         In connection with the Guggenheim  credit  facility,  we entered into a
registration  rights  agreement with the selling  shareholders.  Pursuant to the
registrant  rights  agreement,  as  amended,  we agreed  to file a  registration
statement on Form S-3 registering the resale by the selling shareholders of 125%
of the  shares of common  stock to be issued  upon  exercise  of their  warrants
described in this prospectus and to keep the  registration  statement  effective
until the date that all the shares of common stock  covered by the  registration
statement on Form S-3 have been sold or may be sold by each selling  shareholder
without  volume  restrictions   pursuant  to  Rule  144  promulgated  under  the
Securities Act of 1933. This registration rights agreement provides that we must
register for resale the common  shares by November 13, 2006.  This  registration
rights  agreement,  as  amended,  also  provides  that if we do not comply  with
certain covenants  regarding the registration for resale of the common shares by
January 12, 2006, then we must pay each of the selling  shareholders a fee of 1%
of the aggregate exercise price of the warrants held by such selling shareholder
(to the extent the warrants are then  exercisable and the exercise price is less
than the then-current  market price) for each month after such date that we fail
to  comply  with  such  registration  covenants  until  such  non-compliance  is
remedied.   Pursuant  to  the  registration  rights  agreement,   we  filed  the
registration  statement of which this  prospectus is a part with the  Securities
and Exchange Commission.


                                       11



         The warrants issued on June 16, 2006 in relation to the credit facility
contain "weighted average" antidilution  adjustment provisions which provide for
adjustments to the exercise price of the warrants under certain circumstances if
we were to issue additional securities at a price below the then applicable base
exercise price or below the then  applicable  market price for our common stock.
As a result, if these adjustment  provisions are triggered,  we may be obligated
to issue  additional  shares of common stock upon exercise of the  warrants.  To
address this possible  issuance of additional  shares,  we are  registering  the
additional 25% of shares  currently  issuable upon exercise of the warrants.  In
addition,  as described above, the registration rights agreement we entered into
with the selling shareholders obligates us to register these additional shares.

         Other  than  the  transactions  described  above,  we had  no  material
relationship with any selling  shareholder  during the three years preceding the
date of this prospectus.

SELLING SHAREHOLDERS TABLE

         The following table sets forth: (1) the name of each of the shareholder
for whom we are registering  shares under this registration  statement;  (2) the
number of shares of our common stock beneficially owned by each such shareholder
prior to this offering  (including  all shares of common stock issuable upon the
exercise of warrants as described  above,  whether or not exercisable  within 60
days of the date  hereof);  (3) the number of shares of our common stock offered
by such shareholer  pursuant to this  prospectus;  and (4) the number of shares,
and (if one  percent  or more) the  percentage  of the total of the  outstanding
shares,  of our common stock to be beneficially  owned by each such  shareholder
after  this  offering,  assuming  that all of the  shares  of our  common  stock
beneficially  owned  by each  such  shareholder  and  offered  pursuant  to this
prospectus are sold and that each such shareholder acquires no additional shares
of our common stock prior to the completion of this offering. Such data is based
upon information provided by each selling shareholder.

         We do not know how long the selling  shareholders  will hold the shares
before  selling them or how many shares they will sell, and we currently have no
agreements,  arrangements or understandings with any of the selling shareholders
regarding the sale of any shares.  The shares offered by this  prospectus may be
offered from time to time by the selling  shareholders listed below. The selling
shareholders may elect not to sell any or all of the securities  offered by this
prospectus.

         Pursuant to the terms of the warrants held by the selling shareholders,
each selling  shareholder  shall not, without the approval of our  shareholders,
exercise  any portion of the warrant  held by it to the extent that after giving
effect to such issuance after  exercise,  the shares issued with respect to such
warrant,  together with any other warrants  issued to the selling  shareholders,
would  represent  more  than  19.9% of the  shares of common  stock  issued  and
outstanding  as of June 16,  2006.  The  shares of common  stock and  percentage
ownership listed in this table do not reflect these contractual limitations on a
selling  shareholder's  ability to acquire  common  shares upon  exercise of its
warrants.



                                                                                                    PERCENTAGE OF
                                                               COMMON STOCK      COMMON STOCK       COMMON STOCK
                                            COMMON STOCK      BEING OFFERED       OWNED UPON         OWNED UPON
                                           OWNED PRIOR TO    PURSUANT TO THIS    COMPLETION OF      COMPLETION OF
NAME                                       THE OFFERING(1)    PROSPECTUS(2)     THIS OFFERING      THIS OFFERING(3)
---------------------------------------   ----------------   ----------------   ----------------   ----------------
                                                                                                      
Midland National Life Insurance
Company (4) ...........................          1,071,429          1,339,287                  0                  0
North American Company for Life and
Health Insurance (5) ..................            714,286            892,858                  0                  0



                                       12





                                                                                                    PERCENTAGE OF
                                                               COMMON STOCK      COMMON STOCK       COMMON STOCK
                                            COMMON STOCK      BEING OFFERED       OWNED UPON         OWNED UPON
                                           OWNED PRIOR TO    PURSUANT TO THIS    COMPLETION OF      COMPLETION OF
NAME                                       THE OFFERING(1)    PROSPECTUS(2)     THIS OFFERING      THIS OFFERING(3)
---------------------------------------   ----------------   ----------------   ----------------   ----------------
                                                                                                      
Orpheus Holdings LLC (6) ..............          2,071,428          2,589,285                  0                  0
Durham Capital Corporation (7) ........             77,143             96,429                  0                  0
TOTAL .................................          3,934,286          4,917,859                  0                  0


----------
(1)      Includes  for each selling  shareholder  the number of shares of common
         stock   issuable  upon  exercise  of  warrants  held  by  such  selling
         shareholder.

(2)      Pursuant to the terms of the registration  rights agreement,  we agreed
         to register for the selling shareholders the number of shares of common
         stock  determined  by  multiplying  125% of all  shares  issuable  upon
         exercise of the warrants.

(3)      Percentage ownership is based upon 30,543,763 shares of Common Stock of
         the  Registrant   issued  and  outstanding  as  of  the  date  of  this
         prospectus.

(4)      The shares of common stock offered pursuant to this prospectus  consist
         of 125% of 1,071,429  shares  issuable  upon exercise of a warrant that
         has a term of 10 years.  This  warrant is  exercisable  (or will become
         exercisable  upon the funding of a specific portion of the initial term
         loan) at a price of $1.88 per share with  respect  to  214,286  shares,
         $2.00 per share with  respect to 214,286  shares,  $3.00 per share with
         respect to  214,286  shares,  $3.75 per share  with  respect to 214,286
         shares and $4.50 per share with respect to 214,285 shares. A portion of
         the warrant  will not become  exercisable  unless and until a specified
         portion of the initial term loan is actually funded by the lenders. The
         exercise  prices  are  subject  to  adjustment  for  certain   dilutive
         issuances  pursuant  to the terms of the  warrant.  Stephen D.  Sautel,
         Managing Director of Guggenheim  Partners Advisory Company,  as advisor
         to  Midland  National  Life  Insurance  Company,  exercises  voting and
         investment  authority over the shares held by this selling shareholder.
         Midland   National  Life  Insurance   Company  is  an  affiliate  of  a
         broker/dealer  but  certifies  that  it  acquired  the  warrant  in the
         ordinary course of business for investment purposes, and at the time of
         the  purchase of the  warrant,  had no  agreements  or  understandings,
         directly or indirectly, with any person to distribute the shares.

(5)      The shares of common stock offered pursuant to this prospectus  consist
         of 125% of 714,286 shares  issuable upon exercise of a warrant that has
         a term of 10  years.  This  warrant  is  exercisable  (or  will  become
         exercisable  upon the funding of a specific portion of the initial term
         loan) at a price of $1.88 per share with  respect  to  142,857  shares,
         $2.00 per share  with  respect  142,857  shares,  $3.00 per share  with
         respect to  142,857  shares,  $3.75 per share  with  respect to 142,857
         shares and $4.50 per share with respect to 142,858 shares. A portion of
         the warrant  will not become  exercisable  unless and until a specified
         portion of the initial term loan is actually funded by the lenders. The
         exercise  prices  are  subject  to  adjustment  for  certain   dilutive
         issuances  pursuant  to the terms of the  warrant.  Stephen D.  Sautel,
         Managing Director of Guggenheim  Partners Advisory Company,  as advisor
         to North  American  Company  for Life and Health  Insurance,  exercises
         voting and  investment  authority  over the shares held by this selling
         shareholder. North American Company for Life and Health Insurance is an
         affiliate of a broker/dealer but certifies that it bought the shares in
         the ordinary  course of business for  investment  purposes,  and at the
         time of the purchase of the shares to be resold,  had no  agreements or
         understandings,  directly or indirectly,  with any person to distribute
         the shares.

(6)      The shares of common stock offered pursuant to this prospectus  consist
         of 125% of 2,071,428  shares  issuable  upon exercise of a warrant that
         has a term of 10 years.  This  warrant is  exercisable  (or will become
         exercisable  upon the funding of a specific portion of the initial term
         loan) at a price of $1.88 per share with  respect  to  414,286  shares,
         $2.00 per share with  respect to 414,285  shares,  $3.00 per share with
         respect to  414,286  shares,  $3.75 per share  with  respect to 414,285
         shares and $4.50 per share with respect to 414,286 shares. A portion of
         the warrant  will not become  exercisable  unless and until a specified
         portion of the initial term loan is actually funded by the lenders. The
         exercise  prices  are  subject  to  adjustment  for  certain   dilutive
         issuances  pursuant  to the terms of the  warrant.  Stephen D.  Sautel,
         Managing Director of Guggenheim  Partners Advisory Company,  as advisor
         to Orpheus Holdings LLC, exercises voting and investment authority over
         the shares held by this selling shareholder. Orpheus Holdings LLC is an


                                       13



         affiliate of a broker/dealer but certifies that it bought the shares in
         the ordinary  course of business for  investment  purposes,  and at the
         time of the purchase of the shares to be resold,  had no  agreements or
         understandings,  directly or indirectly,  with any person to distribute
         the shares.

(7)      The shares of common stock offered pursuant to this prospectus  consist
         of 125% of 77,143 shares issuable upon exercise of a warrant that has a
         term of 10 years.  This  warrant is  exercisable  at price of $1.88 per
         share, subject to adjustment for certain dilutive issuances.  A portion
         of  this  warrant  will  not  become  exercisable  unless  and  until a
         specified  portion of the initial  term loan is actually  funded by the
         lenders.   Sylvester  F.  Miniter,  the  President  of  Durham  Capital
         Corporation,  exercises voting and investment authority over the shares
         held by this selling shareholder.


                                       14



                              PLAN OF DISTRIBUTION

         The shares of our common stock offered  pursuant to this prospectus may
be offered and sold from time to time by the selling  shareholders listed in the
preceding section, or their donees, transferees, pledgees or other successors in
interest that receive such shares as a gift or other non-sale related  transfer.
These selling shareholders will act independently of us in making decisions with
respect to the timing, manner and size of each sale.

         The  selling  shareholders  and any of their  pledgees,  assignees  and
successors-in-interest  may, from time to time,  sell any or all of their shares
of common stock on any stock exchange,  market or trading  facility on which the
shares  are traded or in private  transactions.  These  sales may be at fixed or
negotiated  prices.  The  selling  shareholders  may  use any one or more of the
following methods when selling shares:

         o        Ordinary brokerage  transactions and transactions in which the
                  broker-dealer solicits purchasers;

         o        Block trades in which the  broker-dealer  will attempt to sell
                  the shares as agent but may  position  and resell a portion of
                  the block as principal to facilitate the transaction;

         o        Purchases by a  broker-dealer  as principal  and resale by the
                  broker-dealer for its account;

         o        An exchange  distribution  in accordance with the rules of the
                  applicable exchange;

         o        Privately negotiated transactions;

         o        Settlement  of short sales entered into after the date of this
                  prospectus;

         o        Broker-dealers may agree with the selling shareholders to sell
                  a specified  number of such shares at a  stipulated  price per
                  share;

         o        Through put or call transactions relating to the shares;

         o        Through the writing or  settlement of options or other hedging
                  transactions,   whether   through  an  options   exchange   or
                  otherwise;

         o        A combination of any such methods of sale; and

         o        Any other method permitted by applicable law.

         The selling  shareholders may also sell shares under Rule 144 under the
Securities Act of 1933, if available, rather than under this prospectus.

         In connection  with the sale of our common stock or interests  therein,
the selling shareholders may enter into hedging transactions with broker-dealers
or other financial institutions,  which may in turn engage in short sales of the
common stock in the course of hedging the  positions  they  assume.  The selling
shareholders  may also sell shares of our common  stock short and deliver  these
securities  to close out their  short  positions,  or loan or pledge  the common
stock to  broker-dealers  that in turn may sell these  securities.  The  selling
shareholders   may  also  enter   into   option  or  other   transactions   with


                                       15



broker-dealers  or other  financial  institutions or the creation of one or more
derivative  securities which require the delivery to such broker-dealer or other
financial  institution of shares offered by this  prospectus,  which shares such
broker-dealer  or  other  financial  institution  may  resell  pursuant  to this
prospectus (as supplemented or amended to reflect such transaction).

         Broker-dealers  engaged by the  selling  shareholders  may  arrange for
other  broker-dealers  to  participate  in  sales.  Broker-dealers  may  receive
commissions or discounts from the selling shareholders (or, if any broker-dealer
acts as agent for the purchaser of shares,  from the purchaser) in amounts to be
negotiated.  The  selling  shareholders  do not  expect  these  commissions  and
discounts to exceed what is customary in the types of transactions involved. Any
profits on the  resale of shares of common  stock by a  broker-dealer  acting as
principal might be deemed to be underwriting  discounts or commissions under the
Securities  Act.  Discounts,  concenssions,   commissions  and  similar  selling
expenses,  if any,  attitributable  to the  sale of  shares  will be  borne by a
selling shareholder.  The selling shareholders may agree to indemnify any agent,
dealer or broker-dealer that participates in transactions involving sales of the
shares if liabilities are imposed on that person under the Securities Act.

         The  selling  shareholders  may  from  time to time  pledge  or grant a
security  interest  in some or all of the shares of common  stock  owned by them
and,  if they  default in the  performance  of their  secured  obligations,  the
pledgees or secured  parties may offer and sell the shares of common  stock from
time to time under this  prospectus,  or under an amendment  to this  prospectus
under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933
amending the list of selling shareholders to include the pledgee,  transferee or
other successors in interest as selling shareholders under this prospectus.

         The  selling  shareholders  and any  broker-dealers  or agents that are
involved  in selling  the shares may be deemed to be  "underwriters"  within the
meaning of the  Securities  Act of 1933 in connection  with such sales.  In such
event, any commissions  received by such broker-dealers or agents and any profit
on the resale of the shares  purchased by them may be deemed to be  underwriting
commissions  or  discounts  under  the  Securities  Act of  1933.

         We are  required  to pay  certain  fees  and  expenses  incurred  by us
incident to the  registration  of the shares.  We have agreed to  indemnify  the
selling  shareholders against certain losses,  claims,  damages and liabilities,
including liabilities under the Securities Act.

         If the selling  shareholders  use this  prospectus  for any sale of the
shares  of  common  stock,  they  will be  subject  to the  prospectus  delivery
requirements of the Securities Act. In addition,  any securities covered by this
prospectus  which qualify for sale pursuant to Rule 144 under the Securities Act
may be sold under Rule 144 rather  than  under  this  prospectus.  Each  selling
shareholder  has advised us that they have not entered  into any  agreements  or
understandings  with any person to  distribute  the resale  shares.  There is no
underwriter or  coordinating  broker acting in connection with the proposed sale
of the resale shares by the selling shareholders.

         We agreed to keep this  prospectus  effective  until the earlier of (i)
the date on which the shares may be resold by each selling  shareholder  without
registration  and  without  regard to any volume  limitations  by reason of Rule
144(k) under the  Securities Act or any other rule of similar effect or (ii) all
of the shares have been sold  pursuant to the  prospectus  or Rule 144 under the
Securities  Act or any other rule of similar  effect.  The resale shares will be
sold only through  registered or licensed  brokers or dealers if required  under
applicable  state securities  laws. In addition,  in certain states,  the resale
shares may not be sold unless they have been registered or qualified for sale in
the applicable  state or an exemption  from the  registration  or  qualification
requirement is available and is complied with.


                                       16



         Under  applicable rules and regulations  under the Securities  Exchange
Act of 1934, any person engaged in the distribution of the resale shares may not
simultaneously  engage in market  making  activities  with respect to our common
stock  for a  period  of two  business  days  prior to the  commencement  of the
distribution.   In  addition,  the  selling  shareholders  will  be  subject  to
applicable  provisions  of the  Exchange  Act  and  the  rules  and  regulations
thereunder,  including Regulation M, which may limit the timing of purchases and
sales of shares of our common  stock by the  selling  shareholders  or any other
person.

                       WHERE YOU CAN FIND MORE INFORMATION

         We have filed a  registration  statement  on Form S-3 with the SEC with
respect to the common stock offered by this prospectus.  This prospectus,  which
constitutes a part of the  registration  statement,  does not contain all of the
information  set  forth  in  the  registration  statement  or the  exhibits  and
schedules that are part of the  registration  statement and it  incorporates  by
reference,  rather than stating,  certain important  information included in our
filings  with the SEC.  You may read and copy any  document we file at the SEC's
public reference room at 100 F. Street, N.E.,  Washington,  D.C. 20549. We refer
you to the  registration  statement and the exhibits and  schedules  thereto for
further information with respect to us and our common stock. Please call the SEC
at 1-800-SEC-0330 for further  information on the public reference room. Our SEC
filings are also available to the public from the SEC's website at www.sec.gov.

         We are subject to the information and periodic  reporting  requirements
of  the  Securities   Exchange  Act  of  1934  and,  in  accordance  with  those
requirements, will continue to file periodic reports, proxy statements and other
information  with the SEC. These periodic  reports,  proxy  statements and other
information  will be available  for  inspection  and copying at the SEC's public
reference rooms and the SEC's website referred to above.

         The SEC allows us to "incorporate by reference" the information we file
with the SEC, which means that we can disclose  important  information to you by
referring to those  documents.  We incorporate by reference the documents listed
below and any additional documents filed by us with the SEC under Section 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934 until this offering of
securities is  terminated.  The  information  we  incorporate by reference is an
important part of this  prospectus,  and any information that we file later with
the SEC will automatically update and supersede this information.

         The documents we incorporate by reference are:

         1.       Our Annual Report on Form 10-K for the year ended December 31,
                  2005 (File No. 000-26006);

         2.       Our  Quarterly  Report on Form 10-Q for the  quarterly  period
                  ended March 31, 2006 (File No. 000-26006)


         3.       Our  Quarterly  Report on Form 10-Q for the  quarterly  period
                  ended June 30, 2006 (File No. 000-26006);

         4.       Our  Current  Report on Form 8-K as filed on January  20, 2006
                  (File No. 000-26006);

         5.       Our  Current  Report on Form 8-K as filed on January  27, 2006
                  (File No. 000-26006);

         6.       Our  Current  Report  on Form 8-K as filed on March  30,  2006
                  (File No. 000-26006);

         7.       Our Current Report on Form 8-K as filed on April 3, 2006 (File
                  No. 000-26006);

         8.       Our Current  Report on Form 8-K as filed on May 16, 2006 (File
                  No. 000-26006);

         9.       Our  Current  Report on Form 8-K filed on June 14,  2006 (File
                  No. 000-26006);

        10.       Our  Current  Report on Form 8-K filed on June 21,  2006 (File
                  No. 000-26006);


                                       17



         11.      Our  Current  Report on Form 8-K filed on June 30,  2006 (File
                  No. 000-26006);

         12.      Our Current Report on Form 8-K filed on July 6, 2006 (File No.
                  000-26006);

         13.      Our Current  Report on Form 8-K filed on August 14, 2006 (File
                  No. 000-26006);

         14.      The   description  of  our  common  stock   contained  in  our
                  Registration  Statements on Form 8-A as filed on May 14, 1995,
                  July 14, 1995 and August 7, 1995 (File No. 000-26006); and

         15.      All other  reports  filed by us pursuant  to Section  13(a) or
                  15(d) of the  Securities  Exchange Act of 1934 since  December
                  31, 2005,  including  all such reports filed after the date of
                  the initial registration  statement and prior to effectiveness
                  of the registration statement.


         You may  request a copy of these  filings,  at no cost,  by  writing or
calling  us at  Tarrant  Apparel  Group,  3151 East  Washington  Boulevard,  Los
Angeles, California 90023, telephone number (323) 780-8250,  Attention:  Corazon
Reyes.

         You should rely only on the information contained in this prospectus or
any supplement and in the documents incorporated by reference above. We have not
authorized anyone else to provide you with different information. You should not
assume that the  information  in this  prospectus  or any  supplement  or in the
documents  incorporated by reference is accurate on any date other than the date
on the front of those documents.

                                  LEGAL MATTERS

         Stubbs Alderton & Markiles, LLP, Sherman Oaks, California, has rendered
to Tarrant  Apparel Group a legal opinion as to the validity of the common stock
covered by this prospectus.

                                     EXPERTS

         The consolidated  financial  statements and schedule of Tarrant Apparel
Group,   incorporated  by  reference  into  this  Prospectus  and   Registration
Statement, at December 31, 2005 and for the year then ended have been audited by
Singer  Lewak  Greenbaum & Goldstein  LLP (our  current  independent  registered
public  accounting  firm) and are included in reliance upon such report given on
the authority of such firm as experts in accounting and auditing.

         The consolidated  financial  statements and schedule of Tarrant Apparel
Group,   incorporated  by  reference  into  this  Prospectus  and   Registration
Statement,  at December  31,  2004,  and for each of the two years in the period
then  ended have been  audited by Grant  Thornton  LLP (our  former  independent
registered  public  accounting  firm)  as set  forth  in  their  report  thereon
incorporated  by reference,  and are included in reliance upon such report given
on the authority of such firm as experts in accounting and auditing.


                                       18



--------------------------------------------------------------------------------
You should rely only on the information incorporated by reference or provided in
this  prospectus or any  supplement to this  prospectus.  We have not authorized
anyone else to provide you with different information.  The selling shareholders
should  not make an offer of these  shares in any  state  where the offer is not
permitted.  You should not assume that the information in this prospectus or any
supplement to this  prospectus is accurate as of any date other than the date on
the cover page of this prospectus or any supplement.
--------------------------------------------------------------------------------


                              --------------------

                              TARRANT APPAREL GROUP

                                   PROSPECTUS

                              --------------------






                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

         The following table itemizes the expenses incurred by the Registrant in
connection  with the offering.  All the amounts  shown are estimates  except the
Securities and Exchange Commission registration fee.

Registration fee - Securities and Exchange Commission.............  $       911
Legal Fees and Expenses...........................................       30,000
Accounting Fees and Expenses......................................       30,000
Miscellaneous Expenses............................................          500
                                                                    ------------
     Total........................................................  $    61,411
                                                                    ============

ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

         The  Registrant's  Restated  Articles of  Incorporation  and its Bylaws
provide for the indemnification by the Registrant of each director,  officer and
employee of the  Registrant to the fullest  extent  permitted by the  California
General Corporation Law, as the same exists or may hereafter be amended. Section
204 of the General  Corporation Law of the State of California (the  "California
Law")  permits  the  limitation  of the  personal  liability  of a director  for
monetary  damages in an action brought by or in the right of the corporation for
breach of a director's  duties to the  corporation  and its  shareholders  under
certain  conditions  and  subject to  certain  limitations.  Section  317 of the
California General  Corporation Law provides in relevant part that a corporation
may  indemnify  any person who was or is a party or is  threatened  to be made a
party to any  threatened,  pending  or  completed  action,  suit or  proceeding,
whether civil,  criminal,  administrative or investigative (other than an action
by or in the right of the corporation) by reason of the fact that such person is
or was a director,  officer, employee or agent of the corporation,  or is or was
serving at the request of the  corporation as a director,  officer,  employee or
agent  of  another  corporation,  partnership,  joint  venture,  trust  or other
enterprise,  against expenses (including attorneys' fees), judgments,  fines and
amounts paid in settlement  actually and  reasonably  incurred by such person in
connection  with such action,  suit or  proceeding  if such person acted in good
faith  and in a  manner  such  person  reasonably  believed  to be in  the  best
interests  of the  corporation,  and,  with  respect to any  criminal  action or
proceeding,  had no  reasonable  cause to  believe  such  person's  conduct  was
unlawful.

         In addition,  Section 317 provides that a corporation may indemnify any
person  who  was or is a  party  or is  threatened  to be  made a  party  to any
threatened,  pending  or  completed  action  or suit by or in the  right  of the
corporation  to procure a judgment  in its favor by reason of the fact that such
person is or was a director,  officer, employee or agent of the corporation,  or
is or was serving at the  request of the  corporation  as a  director,  officer,
employee or agent of another corporation,  partnership,  joint venture, trust or
other  enterprise  against  expenses  (including  attorneys'  fees) actually and
reasonably  incurred by such person in connection with the defense or settlement
of such action or suit if such  person  acted in good faith and in a manner such
person  reasonably  believed to be in the best interests of the  corporation and
its  shareholders.  No  indemnification  shall be made in  respect of any claim,
issue or matter as to which such person shall have been adjudged to be liable to
the  corporation in the performance of that person's duty to the corporation and
its  shareholders,  unless and only to the  extent  that the court in which such
action or suit is or was pending shall determine upon application  that, in view
of all the


                                      II-1



circumstances  of the case,  such  person is fairly and  reasonably  entitled to
indemnity  for such  expenses  and then only to the extent  that the court shall
determine.  California law further  provides that nothing in the above described
provisions shall be deemed exclusive of any other rights to  indemnification  or
advancement  of expenses  to which any person may be  entitled  under any bylaw,
agreement, vote of shareholders or disinterested directors or otherwise.

         The  Registrant  has entered  into  separate  but  identical  indemnity
agreements (the "Indemnity Agreements") with each director of the Registrant and
certain  officers of the Registrant (the  "Indemnitees").  Pursuant to the terms
and  conditions of the Indemnity  Agreements,  the Registrant  indemnified  each
Indemnitee  against any amounts which he or she becomes legally obligated to pay
in  connection  with any  claim  against  him or her  based  upon any  action or
inaction  which he or she may commit,  omit or suffer while acting in his or her
capacity as a director  and/or  officer of the  Registrant or its  subsidiaries,
provided,  however,  that  Indemnitee  acted  in  good  faith  and  in a  manner
Indemnitee  reasonably believed to be in or not opposed to the best interests of
the Registrant and, with respect to any criminal action, had no reasonable cause
to believe Indemnitee's Conduct was unlawful.

         The  Registrant  maintains  an insurance  policy  pursuant to which the
directors  and officers of the  Registrant  are  insured,  within the limits and
subject to the limitations of the policy, against certain expenses in connection
with the defense of certain claims,  actions, suits or proceedings,  and certain
liabilities which might be imposed as a result of such claims, actions, suits or
proceedings,  which may be  brought  against  them by  reason of their  being or
having been such directors and officers.


                                      II-2



ITEM 16. EXHIBITS.

EXHIBIT
 NUMBER                               DESCRIPTION
-------  -----------------------------------------------------------------------

3.1      Restated  Articles of Incorporation of the Registrant  (incorporated by
         reference to the Registrant's  Registration Statement on Form S-1 filed
         with the Securities and Exchange Commission on May 4, 1995).

3.1.1    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the Registrant's Quarterly Report on Form
         10Q for the quarter ending June 30, 2002).

3.1.2    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the Registrant's Quarterly Report on Form
         10Q for the quarter ending June 30, 2002).

3.1.3    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the  Registrant's  Current Report on Form
         8-K filed December 10, 2003).

3.2      Restated  Bylaws of the  Registrant  (incorporated  by reference to the
         Registrant's   Registration  Statement  on  Form  S-1  filed  with  the
         Securities and Exchange Commission on May 4, 1995).

4.1      Specimen of Common Stock  Certificate  (incorporated by reference to an
         Exhibit to Amendment No. 1 to Registration  Statement on Form S-1 filed
         on July 15, 1995).

4.2      Rights  Agreement,  dated as of November 21,  2003,  by and between the
         Registrant   and   Computershare   Trust   Company,   as  Rights  Agent
         (incorporated by reference to Exhibit 4.4 to the Current Report on Form
         8-K filed on November 21, 2003).

4.3      Certificate of Determination of Preferences,  Rights and Limitations of
         Series B Preferred Stock (incorporated by reference to the Registrant's
         Current Report on Form 8-K/A filed December 12, 2003).


5.1      Opinion and Consent of Stubbs Alderton & Markiles, LLP.*

10.1     Warrants  Purchase  Agreement dated June 16, 2006, by and among Tarrant
         Apparel Group,  Orpheus Holdings,  LLC, North American Company for Life
         and Health  Insurance,  Midland  National  Life  Insurance  Company and
         Durham Capital Corporation.*

10.2     Registration  Rights  Agreement,  dated  June 16,  2006,  by and  among
         Tarrant Apparel Group,  Orpheus  Holdings,  LLC, North American Company
         for Life and Health Insurance,  Midland National Life Insurance Company
         and Durham Capital Corporation.*

10.2.1   Amendment No. 1 to Registration  Rights  Agreement,  dated as of August
         11, 2006, by and among Tarrant Apparel Group,  Orpheus  Holdings,  LLC,
         North American Company for Life and Health Insurance,  Midland National
         Life Insurance Company and Durham Capital Corporation.*

10.3     Form of Warrants to Purchase Common Stock issued June 16, 2006.*

10.4     Warrant to Purchase Common Stock dated June 16, 2006, issued by Tarrant
         Apparel Group to Durham Capital Corporation.*


23.1     Consent  of  Singer  Lewak  Greenbaum  &  Goldstein  LLP,   Independent
         Registered Public Accounting Firm.

23.2     Consent of Grant Thornton LLP, Independent Registered Public Accounting
         Firm.


23.3     Consent of Stubbs Alderton & Markiles, LLP (included in Exhibit 5.1).*

24.1     Power of Attorney (included on signature page).*

----------
* Previously filed.



                                      II-3



ITEM 17. UNDERTAKINGS.

(a)      The undersigned Registrant hereby undertakes:

         (1)      To file,  during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:

                  (i)      To  include  any   prospectus   required  by  Section
10(a)(3) of the Securities Act of 1933;

                  (ii)To   reflect in the prospectus any facts or events arising
after the  effective  date of the  registration  statement  (or the most  recent
post-effective  amendment  thereof)  which,  individually  or in the  aggregate,
represent a fundamental  change in the information set forth in the registration
statement.  Notwithstanding the foregoing, any increase or decrease in volume of
securities  offered (if the total dollar value of  securities  offered would not
exceed that which was  registered) and any deviation from the low or high end of
the estimated  maximum offering range may be reflected in the form of prospectus
filed with the  Commission  pursuant  to Rule 424(b) if, in the  aggregate,  the
changes in volume and price  represent  no more than a 20 percent  change in the
maximum  aggregate  offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement;

                  (iii)    To include any material  information  with respect to
the plan of distribution not previously disclosed in the registration  statement
or any  material  change  to such  information  in the  registration  statement;
provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this
section  do  not  apply  if  the  information  required  to  be  included  in  a
post-effective  amendment by those paragraphs is contained in reports filed with
or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934 that are incorporated by reference in the
registration  statement,  or is contained in a form of prospectus filed pursuant
to Rule 424(b) that is part of the registration statement.

         (2)      That, for the purpose of determining  any liability  under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial BONA
FIDE offering thereof.

         (3)      To  remove  from  registration  by means  of a  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.


         (4)      That,  for the  purpose  of  determining  liability  under the
Securities  Act of 1933 to any  purchaser,  if the Registrant is subject to Rule
430C,  each  prospectus  filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration statements relying on
Rule 430B or other than  prospectuses  filed in reliance on Rule 430A,  shall be
deemed to be part of and included in the  registration  statement as of the date
it is first used after effectiveness.  Provided, however, that no statement made
in a  registration  statement  or  prospectus  that is part of the  registration
statement or made in a document incorporated or deemed incorporated by reference
into the  registration  statement or prospectus that is part of the registration
statement  will, as to a purchaser with a time of contract of sale prior to such
first use,  supersede or modify any statement that was made in the  registration
statement or prospectus that was part of the  registration  statement or made in
any such document immediately prior to such date of first use.


(b)      The  undersigned  Registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
Registrant's  annual  report  pursuant to section  13(a) or section 15(d) of the
Securities  Exchange Act of 1934 and (and, where  applicable,  each filing of an
employee  benefit  plan's  annual  report  pursuant  to  section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial BONA FIDE offering thereof.

(c)      Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the Registrant pursuant to the foregoing provisions or otherwise, the Registrant
has been advised that in the opinion of the Securities  and Exchange  Commission
such  indemnification  is against  public policy as expressed in the Act and is,
therefore  unenforceable.  In the event that a claim for indemnification against
such liabilities  (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of


                                      II-4



the Registrant in the successful  defense of any action,  suit or proceeding) is
asserted by such director,  officer or controlling person in connection with the
securities being registered, the Registrant will, unless in the opinion of their
counsel the matter has been settled by controlling precedent,  submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
adjudication of such issue.


                                      II-5



                                   SIGNATURES


         Pursuant  to the  requirements  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of Los Angeles,  State of  California,  on September 8,
2006.


                                      TARRANT APPAREL GROUP

                                      By: /s/ Corazon Reyes
                                         -----------------------------------
                                      Corazon Reyes, Chief Financial Officer



         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates stated.

    SIGNATURE                      TITLE                               DATE


        *              Chief Executive Officer and             September 8, 2006
--------------------   Chairman of the Board of Directors
Gerard Guez            (Principal Executive Officer)

        *              Vice Chairman of the Board of           September 8, 2006
--------------------   Directors
Todd Kay

        *              Chief Financial Officer,                September 8, 2006
--------------------   Treasurer and Director
Corazon Reyes

                       (Principal Financial and
--------------------   Accounting Officer) Director
Milton Koffman

                       Director
--------------------
Stephane Farouze

        *              Director                                September 8, 2006
--------------------
Mitchell Simbal

        *              Director                                September 8, 2006
--------------------
Joseph Mizrachi

        *              Director                                September 8, 2006
--------------------
Simon Mani

*By: /s/ Corazon Reyes
     ----------------------------------
     Corazon Reyes, as Attorney-In-Fact



                                       S-1



                                  EXHIBIT INDEX

EXHIBIT
 NUMBER                              DESCRIPTION
-------  -----------------------------------------------------------------------

3.1      Restated  Articles of Incorporation of the Registrant  (incorporated by
         reference to the Registrant's  Registration Statement on Form S-1 filed
         with the Securities and Exchange Commission on May 4, 1995).

3.1.1    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the Registrant's Quarterly Report on Form
         10Q for the quarter ending June 30, 2002).

3.1.2    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the Registrant's Quarterly Report on Form
         10Q for the quarter ending June 30, 2002).

3.1.3    Certificate  of  Amendment  of  Restated   Articles  of   Incorporation
         (incorporated by reference to the  Registrant's  Current Report on Form
         8-K filed December 10, 2003).

3.2      Restated  Bylaws of the  Registrant  (incorporated  by reference to the
         Registrant's   Registration  Statement  on  Form  S-1  filed  with  the
         Securities and Exchange Commission on May 4, 1995).

4.1      Specimen of Common Stock  Certificate  (incorporated by reference to an
         Exhibit to Amendment No. 1 to Registration  Statement on Form S-1 filed
         on July 15, 1995).

4.2      Rights  Agreement,  dated as of November 21,  2003,  by and between the
         Registrant   and   Computershare   Trust   Company,   as  Rights  Agent
         (incorporated by reference to Exhibit 4.4 to the Current Report on Form
         8-K filed on November 21, 2003).

4.3      Certificate of Determination of Preferences,  Rights and Limitations of
         Series B Preferred Stock (incorporated by reference to the Registrant's
         Current Report on Form 8-K/A filed December 12, 2003).


5.1      Opinion and Consent of Stubbs Alderton & Markiles, LLP.*

10.1     Warrants  Purchase  Agreement dated June 16, 2006, by and among Tarrant
         Apparel Group,  Orpheus Holdings,  LLC, North American Company for Life
         and Health  Insurance,  Midland  National  Life  Insurance  Company and
         Durham Capital Corporation.*

10.2     Registration  Rights  Agreement,  dated  June 16,  2006,  by and  among
         Tarrant Apparel Group,  Orpheus  Holdings,  LLC, North American Company
         for Life and Health Insurance,  Midland National Life Insurance Company
         and Durham Capital Corporation.*

10.2.1   Amendment No. 1 to Registration  Rights  Agreement,  dated as of August
         11, 2006, by and among Tarrant Apparel Group,  Orpheus  Holdings,  LLC,
         North American Company for Life and Health Insurance,  Midland National
         Life Insurance Company and Durham Capital Corporation.*

10.3     Form of Warrants to Purchase Common Stock issued June 16, 2006.*

10.4     Warrant  to  Purchase  Common  Stock,  dated June 16,  2006,  issued by
         Tarrant Apparel Group to Durham Capital Corporation.*


23.1     Consent  of  Singer  Lewak  Greenbaum  &  Goldstein  LLP,   Independent
         Registered Public Accounting Firm.

23.2     Consent of Grant Thornton LLP, Independent Registered Public Accounting
         Firm.


23.3     Consent of Stubbs Alderton & Markiles, LLP (included in Exhibit 5.1).*

24.1     Power of Attorney (included on signature page).*

----------
* Previously filed.



                                      EX-1